Johnson & Johnson News
Print this Article | Send to Colleague
Johnson & Johnson News
Johnson & Johnson Vision, a global leader in eye health, announced clinical data from the latest in myopia research at the American Academy of Optometry's annual meeting (Academy 2020), which kicked off virtually on Oct. 7. Investigators also revealed findings that demonstrate how ACUVUE® OASYS 1-Day with Hydraluxe™ Technology Contact Lenses reduced dry eye symptoms in contact lens wearers who are symptomatic in their habitual lens wear.
"Myopia is a chronic and sometimes progressive disease that poses one of the biggest threats to eye health, with children 12 and younger being the most vulnerable," said Thomas Swinnen, President, North America, Johnson & Johnson Vision Care, Inc. “Johnson & Johnson Vision is taking a holistic approach in collaboration with various universities and research institutes. Together, we are working to deliver new, evidence-based solutions for patients with myopia and their care providers."
For more on the latest research presented at Academy 2020, visit the official Johnson & Johnson Vision virtual press room at http://jnjvision.isebox.net/aao/2020
